MD
Matthew Dahabieh
About Matthew Dahabieh
Data last updated:
Matthew Dahabieh is a Director at Terramera Biosciences (India) Private Limited (since 2024). The company operates in Food and Beverages. Terramera Biosciences (India) Private Limited reported revenue of ₹8.19 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 29 Aug 2024 | 2012 | ₹8.19 Cr (FY 2025) | Active |
Board colleagues of Matthew Dahabieh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Maxwell Nirmal Kumar Samuel | 01960781 | Terramera Biosciences (India) Private Limited | Director |
| Nathanael Baron Kelly | 10742184 | Terramera Biosciences (India) Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Matthew Dahabieh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Matthew Dahabieh
Matthew Dahabieh currently holds 1 directorship: Terramera Biosciences (India) Private Limited (Director, since 29 Aug 2024, revenue ₹8.19 Cr (FY 2025)).
Matthew Dahabieh was first appointed on 29 Aug 2024 as Director at Terramera Biosciences (India) Private Limited.
The current boards of Matthew Dahabieh's companies include Maxwell Nirmal Kumar Samuel (Terramera Biosciences (India) Private Limited), Nathanael Baron Kelly (Terramera Biosciences (India) Private Limited).